Skip to main content

Day: September 17, 2021

Evercel Provides 2021 Business Update

MIAMI, Sept. 17, 2021 (GLOBE NEWSWIRE) — Evercel, Inc. [OTC Pink: EVRC] today issued the following letter to shareholders, providing an update on the Company’s business as it approaches its Annual Meeting: Dear Valued Shareholders: It has been an active period at Evercel and we are very excited about our holdings, positioning and path forward. We are writing to provide some business highlights ahead of the Company’s Annual Meeting, which will be held on October 7, 2021 at 10:00am ET. Put plainly, we have assembled a great asset base, which we believe is valuable now and will be more so in the future. Since 2012, we have grown $18 million of cash into approximately $80 million worth of assets, after fees. Importantly, we believe there is significant incremental, embedded value in these assets that is yet to be recognized by the...

Continue reading

PyroGenesis’ CEO to Present at the Sidoti & Company Fall Virtual Small Cap Investor Conference on September 22

MONTREAL, Sept. 17, 2021 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (NASDAQ: PYR) (TSX: PYR) (FRA: 8PY), a high-tech Company (hereinafter referred to as the “Company” or “PyroGenesis”), that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions to reduce greenhouse gases (GHGs), today announced that Mr. P. Peter Pascali, CEO and Chair of PyroGenesis is scheduled to present at the Sidoti & Company Fall Small Cap Investor Conference on September 22, 2021 at 2:30 PM Eastern Time. Mr. Pascali will also be participating in one-on-one meetings with qualified members of the investment community throughout the conference. To access the live presentation, please use the following information:Sidoti & Company Fall Virtual Investor Conference Date: Wednesday,...

Continue reading

American Energy Signs Agreement to Acquire Second Appalachian Basin Energy Services Company

ALLENTOWN, PA, Sept. 17, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — American Energy Partners, Inc. (“American Energy”) (PINK: AEPT), a diversified energy company, is pleased to announce it has agreed to acquire (the “Acquisition”) a second privately held energy services company (“Company”) operating in the Appalachian Basin. The Company focuses on providing facility maintenance, transportation, logistics and environmental services to the energy and industrial sectors.  The Acquisition is anticipated to increase American Energy’s 2022 annualized revenue by six (6) million dollars to over twelve (12) million dollars with forecasted operating income of two (2) million dollars. The acquisition would increase American Energy’s workforce to over 100 employees. Total consideration for the Acquisition will be funded through a combination...

Continue reading

BTCS’s Expanding Blockchain Infrastructure Operations Include Avalanche Node

BTCS first disclosed its plans to secure Avalanche’s Blockchain in April 2021 Silver Spring, MD, Sept. 17, 2021 (GLOBE NEWSWIRE) — BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology focused company, announced it has added Avalanche (“AVAX”) to its blockchain infrastructure operations. At a $14.2 billion market capitalization, AVAX claims to be one of the fastest smart contract platforms offering high transaction throughput. BTCS’ Blockchain Infrastructure Operations are focused on environmentally friendly technologies that utilize proof-of-stake consensus algorithms to process and validate digital asset transactions. While the process is similar to bitcoin mining, the Company’s assets are not tied up in rapidly depreciating ASIC hardware but rather locked in smart contracts allowing for potential long-term...

Continue reading

CMUV Bancorp Announces Tender Offer to Repurchase up to 459,052 Shares of its Common Stock

El Centro, CA, Sept. 17, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — CMUV Bancorp (OTCQB: CMUV) (the “Company”) announced that it has commenced a tender offer to purchase up to 459,052 shares of its common stock at a price per share of $13.05.  The tender offer will expire on October 15, 2021, unless extended. Tenders of shares must be made prior to the expiration of the tender offer. As of September 17, 2021, the Company had 2,295,264 shares of Common Stock issued and outstanding. The 459,052 Shares represent 20% of the total number of Shares issued and outstanding as of September 17, 2021.  “Our Company continues to prosper in these challenging times and, although we cannot predict the future, we remain committed to serving our communities and creating value for shareholders,” said Jon A. Edney, the Company’s President and...

Continue reading

DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) Stakes Claim as New Kid on CaaS Block

NEW YORK, Sept. 17, 2021 (GLOBE NEWSWIRE) — NetworkNewsAudio – DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) announces the availability of a broadcast titled, “Digital Media — The Next Generation: AI, Social for Video and Content to Web Ad Commerce.” To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast To view the full editorial, please visit: https://nnw.fm/06a2V As the new kid on the block, DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) is the unsung public company that is making a name for itself with an A-list client roster through Hashoff, a turnkey enterprise level self-service CaaS (Content-as-a-Service) provider built on proprietary AI/ML technology. DGTL planted its flag in the market in January 2020 when it acquired Hashoff for just two times annual revenue at C$4.5 million in cash and stock...

Continue reading

Positive Results Presented at ESMO 2021 From Randomized, Controlled, Phase 2 Trial of Relacorilant in Patients with Recurrent Platinum-Resistant Ovarian Cancer

Data from Corcept’s 178-patient, randomized, controlled, Phase 2 trial featured in a proffered paper oral presentation at ESMO 2021 Results show statistically significant and clinically relevant benefit experienced by women with recurrent platinum-resistant ovarian cancer who were treated with nab-paclitaxel plus Corcept’s proprietary selective cortisol modulator, relacorilantMENLO PARK, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) — Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, today announced that results from its 178-patient, randomized, controlled, Phase 2 trial of relacorilant plus nab-paclitaxel in patients with recurrent platinum-resistant ovarian...

Continue reading

MasterCraft Boat Holdings, Inc. Updates Guidance for Fiscal First Quarter 2022

Reaffirms Full Year Fiscal 2022 Guidance VONORE, Tenn., Sept. 17, 2021 (GLOBE NEWSWIRE) — MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) (the “Company”) today announced that it is revising its guidance for fiscal first quarter 2022 due principally to a temporary delay in the shipment of a key component from a single engine parts supplier for the Company’s MasterCraft brand. The timing of delivery of these delayed units will shift into the fiscal second quarter 2022. MasterCraft now expects fiscal first quarter 2022 consolidated net sales growth to be up approaching the 30 percent range, compared to the prior estimate of up in the mid-30 percent range; Adjusted EBITDA margins to be in the mid-11 percent range, compared to the prior estimate in the low-14 percent range; and Adjusted Earnings per share for the first quarter to decrease...

Continue reading

Westport Fuel Systems Restates Second Quarter 2021 Financial Statements due to Accounting Error

No impact on gross margin, net income, or the Company’s statement of cash flows.VANCOUVER, British Columbia, Sept. 17, 2021 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. (“WFS” or the “Company“) (TSX:WPRT / Nasdaq:WPRT) announced that it has filed amended and restated unaudited condensed consolidated interim financial statements for the three and six months ended June 30, 2021 (the “Amended Statements“) and related amended and restated management’s discussion and analysis. The Amended Statements were required to correct an accounting error which was identified during an internal review of one of the Company’s subsidiaries’ statutory financial records. All figures are expressed in millions of United States dollars. The Company recently became aware of and corrected a...

Continue reading

Biophytis Reports H1 2021 Financial Results and Provides Business Update

SARA-INT: Positive top line results of Phase 2 study demonstrate efficacy of Sarconeos (BIO101) in sarcopenia and support progress into Phase 3 COVA: DMC second interim analysis shows efficacy results in the promising zone allowing continuation of the phase 2/3 study with Sarconeos (BIO101) in COVID-19. Top line results of the full study are expected in Q1 2022 Manufacturing scale up signed with a major global CDMO to increase potential supply of Sarconeos (BIO10) in anticipation of COVA positive results Biophytis leadership team reinforced with new senior appointments Cash on hand increased to €23 million as of June 30th 2021, compared to €18.8 million as of December 31 2020, following successful IPO on Nasdaq in February 2021. In addition, new convertible bond financing of €32 million signed with AtlasPARIS and CAMBRIDGE, Mass., Sept....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.